SCHEMBL6178664

SCHEMBL6178664

Cc1ccc2c(c1)N(CC(=O)c1ccco1)C(=O)C(NC(=O)Nc1cccc(C(=O)O)c1)CN2C(=O)C(C)(C)C

nearest known ligand 0.52

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CCKBR P32239 19/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6178953 0.92 CCKBR (0.47) CCKBR
SCHEMBL6178856 0.90 CCKBR (0.52) CCKBR
SCHEMBL6179311 0.87 CCKBR (0.55) CCKBR
SCHEMBL6176746 0.86 CCKBR (0.52) CCKBR
SCHEMBL6178809 0.86 CCKBR (0.52) CCKBR
SCHEMBL6178437 0.85 CCKBR (0.48) CCKBR
SCHEMBL6179274 0.83 CCKBR (0.52) CCKBR
SCHEMBL7961864 0.83 CCKBR (0.49) CCKBR
SCHEMBL6180301 0.82 CCKBR (0.47) CCKBR
SCHEMBL6179099 0.82 CCKBR (0.53) CCKBR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0945445-B9 1,5-BENZODIAZEPINE DERIVATIVES ZERIA PHARM CO LTD (JP) 2005-12-28 EP disclosed
EP-0945445-B1 1,5-BENZODIAZEPINE DERIVATIVES ZERIA PHARM CO LTD (JP) 2003-09-03 EP disclosed
US-6239131-B1 WHICH HAVE GASTRIN AND/OR CCK-B (CHOLECYSTOKININ-B) RECEPTOR ANTAGONISM, USEFUL AS REMEDIES FOR GASTRIC ULCER AND GASTROINTESTINAL MOVEMENT DISORDER. ZERIA PHARMACEUTICAL CO., LTD. (JP) 2001-05-29 US disclosed
EP-0945445-A1 1,5-BENZODIAZEPINE DERIVATIVES ZERIA PHARMACEUTICAL CO., LTD. (JP) 1999-09-29 EP disclosed